Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,288,554
  • Shares Outstanding, K 115,357
  • Annual Sales, $ 219,750 K
  • Annual Income, $ -886,120 K
  • 60-Month Beta 1.86
  • Price/Sales 78.10
  • Price/Cash Flow N/A
  • Price/Book 12.46
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.03
  • Most Recent Earnings -1.52 on 05/06/20
  • Next Earnings Date 08/04/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -1.07
  • Number of Estimates 6
  • High Estimate 2.52
  • Low Estimate -1.92
  • Prior Year -2.02
  • Growth Rate Est. (year over year) +47.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.05 +24.84%
on 06/12/20
158.37 -5.37%
on 06/26/20
+11.05 (+7.96%)
since 06/02/20
3-Month
100.02 +49.84%
on 04/03/20
158.37 -5.37%
on 06/26/20
+45.66 (+43.82%)
since 04/02/20
52-Week
69.11 +116.86%
on 08/06/19
158.37 -5.37%
on 06/26/20
+76.90 (+105.39%)
since 07/02/19

Most Recent Stories

More News
Alnylam Reports New 12-Month Interim Data From the ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria

--a^' Safety Profile Consistent With That Observed in the 6-Month Double-Blind Period, With No New Safety Findings a^'

ALNY : 149.87 (+0.74%)
Watch for Alnylam Pharmace to Potentially Rebound After Falling 1.52% Yesterday

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $148.44 to a high of $152.27. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of...

ALNY : 149.87 (+0.74%)
Alnylam Pharmace Rises 1.50% on Heavy Volume: Watch For Potential Pullback

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $152.61 to a high of $156.30. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

ALNY : 149.87 (+0.74%)
New GERM ETF Launched to Tap the Growing Biotech Sector

GERM invests in the hottest emerging biotechnology trends.

MRNA : 58.57 (-4.90%)
ALNY : 149.87 (+0.74%)
BIO : 458.36 (+0.86%)
SBIO : 42.15 (unch)
PBE : 59.49 (+1.09%)
ARKG : 54.06 (+1.64%)
NASDAQ Higher for Fifth Straight Day as Stocks Rally in Final Hour

NASDAQ Higher for Fifth Straight Day as Stocks Rally in Final Hour

SPOT : 271.49 (+4.86%)
TDOC : 208.89 (+5.05%)
UNFI : 18.18 (+3.24%)
ZS : 110.21 (-1.17%)
ACMR : 65.89 (+8.64%)
ESTC : 94.58 (-0.15%)
CRUS : 60.65 (+0.73%)
EVOP : 22.40 (-2.10%)
CMC : 19.83 (-0.20%)
SCHN : 16.85 (-3.38%)
CVET : 17.88 (+3.83%)
XOM : 44.08 (+0.85%)
UNG : 10.08 (+1.92%)
WEAT : 5.04 (-1.37%)
FVRR : 76.50 (+1.73%)
SPTN : 20.90 (+0.92%)
DSPG : 15.64 (-1.01%)
ALNY : 149.87 (+0.74%)
AVXL : 4.95 (-1.00%)
EDIT : 30.53 (-1.04%)
Alnylam to Host Seventh Annual "RNAi Roundtable" Webcast Series

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 7th annual series of "RNAi Roundtable" webinars over the coming weeks. The...

ALNY : 149.87 (+0.74%)
Alnylam to Webcast Presentation at Bank of America Securities 2020 Napa Biopharma Conference

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Bank of America Securities 2020 Napa Biopharma...

ALNY : 149.87 (+0.74%)
Watch for Alnylam Pharmace to Potentially Pullback After Gaining 2.32% Yesterday

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $132.88 to a high of $136.22. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high...

ALNY : 149.87 (+0.74%)
Alnylam???s Share Price Rises YTD on Pipeline Developments

Alnylam's (ALNY) share price rises more than 14% year to date based on pipeline developments.

ALNY : 149.87 (+0.74%)
AKCA : 14.13 (+1.65%)
AYTU : 1.3700 (-2.84%)
AXLA : 5.29 (-3.47%)
Alnylam Announces Publication of ENVISION Phase 3 Study Results for Givosiran in the New England Journal of Medicine

--a^' Givosiran Demonstrated Significant Reduction in the Rate of Porphyria Attacks Compared with Placebo in Patients with AHP -

ALNY : 149.87 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ALNY with:

Business Summary

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies,...

See More

Key Turning Points

2nd Resistance Point 153.74
1st Resistance Point 151.81
Last Price 149.87
1st Support Level 147.21
2nd Support Level 144.54

See More

52-Week High 158.37
Last Price 149.87
Fibonacci 61.8% 124.27
Fibonacci 50% 113.74
Fibonacci 38.2% 103.21
52-Week Low 69.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar